Group Treatment for Anxiety and Depression in a University Outpatient Clinic
Tests a group treatment for anxiety and depression, the Unified Protocol, in adults.
Plain-language title generated from the registry record
Registry title: Unified Protocol Group Treatment in a University Outpatient Clinic
Key facts
- Where
- Bergen, NorwaySee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18-40 with an anxiety disorder and/or depression who want short-term group treatment. A separate group of people without these conditions also takes part.
- Age
- 18 to 40 years
- Sex
- All sexes can join
- Disease stage
- An anxiety disorder and/or unipolar depression (ICD F.3x - 4x)
- Earlier treatment
- Must not be in another psychological treatment. Antidepressant dose must have been stable for at least 6 months. No anxiolytic medication such as benzodiazepines.
Main reasons for not taking part
- Suicidality or self-harm
- Severe psychiatric disorder (bipolar disorder, psychosis)
- Substance use disorder
- Use of anxiolytic medication such as benzodiazepines
- Other ongoing psychological treatment
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 40 years old?
Source: NCT07129941, who can take part
Where in Norway
- Department of Clinical PsychologyBergen, NorwayTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Bergen
- Trial code
- NCT07129941
- Record updated
- 19 August 2025
- Original description
This clinical trial aims to evaluate the effectiveness and underlying processes of change of the Unified Protocol (UP) for treating emotional disorders in a university outpatient clinic. The study will involve 140 patients receiving UP treatment in a group format, delivered either by experienced or novice therapists, along with a non-clinical control group of 45 participants. Participants will self-refer on the basis of advertisement about the study through flyers, posters, project website, social media or local news media. Outcomes will be assessed through self-report measures of well-being, symptoms, emotion regulation, and the non-specific factors of treatment credibility and therapeutic alliance. Additionally, psychophysiological measures of heart rate variability and interoception will be used to explore processes influencing treatment response. Qualitative interviews will complement the quantitative data by capturing participants' perspectives on the treatment and experiences of what contributed to change.Read full original descriptionShow less
Transdiagnostic Group Treatment of Emotional Disorders: A Cross-sectional and Naturalistic Study of Outcome, Change Processes, and Clinical Training
This clinical trial aims to evaluate the effectiveness and underlying processes of change of the Unified Protocol (UP) for treating emotional disorders in a university outpatient clinic. The study will involve 140 patients receiving UP treatment in a group format, delivered either by experienced or novice therapists, along with a non-clinical control group of 45 participants. Participants will self-refer on the basis of advertisement about the study through flyers, posters, project website, social media or local news media. Outcomes will be assessed through self-report measures of well-being, symptoms, emotion regulation, and the non-specific factors of treatment credibility and therapeutic alliance. Additionally, psychophysiological measures of heart rate variability and interoception will be used to explore processes influencing treatment response. Qualitative interviews will complement the quantitative data by capturing participants' perspectives on the treatment and experiences of what contributed to change.
Inclusion: Age 18-40; Fulfilling diagnostic criteria for an anxiety disorder and/or unipolar depression (ICD F.3x - 4x); Motivated for short-term treatment in group format.
Exclusion: Use of anxiolytic medication (i.e., benzodiazepines); Unstable antidepressant medication (i.e., stable dosage <6 months); Severe psychiatric disorder (bipolar disorder, psychosis); Substance use disorders; Suicidality; Self-harm; Other ongoing psychological treatment.